Ibrahim Batal

[Priya Alexander, MD @MPAlexanderMD]

Temporal Proteomic Assessment of Glomerular FAT1 in De Novo Membranous Nephropathy of the Kidney Allograft - Kidney International Reports https://t.co/YMHO93cKem

Good work here by @IbrahimBatal9 in collaboration with our Mayo proteomic core and @MayoClinicPath.

[Ibrahim Batal @IbrahimBatal9]

@fervenzafernan1 @SethiRenalPath @mvargas07 Happy birthday

[Ibrahim Batal @IbrahimBatal9]

@NadaAlachkar @AstridWeins Thank you Nada. Glad you liked the manuscript

[Kidney International @Kidney_Int]

FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection

https://t.co/iTJ39wE8Xb

#kidneytransplant @MayoClinic @MayoClinicNeph @Inserm @CHLeMans @ColumbiaPath @ColumbiaMed @MPAlexanderMD @martacasalmoura

[Mayo Clinic Nephrology @MayoClinicNeph]

FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. #MayoClinicKidney @SethiRenalPath @fervenzafernan1 https://t.co/w4NxDXAOfH.

[Kidney International @Kidney_Int]

Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse #podocytopathy in the #kidneyallograft

https://t.co/KhnMOgpIY7

@harvardmed @ColumbiaPath @CHU_Lille @univ_lille @broadinstitute @ColumbiaKidney @ColumbiaMed @OHSUPathology
#FSGS

[Ibrahim Batal @IbrahimBatal9]

@AstridWeins May he rest in peace

[Ibrahim Batal @IbrahimBatal9]

@LVRiella Beautiful

[Ibrahim Batal @IbrahimBatal9]

@LVRiella Well deserved

[Ibrahim Batal @IbrahimBatal9]

@FridaRosenblum @sam_albadri There is no magic time. Typically a few daybut depending on the injury and sloughing of the endothelium thrombi can persist for longer especially if patient on CNI. Early AMR would be less favored of DSA is negative pretransplant and C4d is neg. Important to rule out ongoing TMA

[Priya Alexander, MD @MPAlexanderMD]

1/6
Thankful to @timucin_taner @MayoTransplant @amjtransplant Sharing our pre-proof, pre-print manuscript Using Imaging Mass Cytometry. Novel #singlecell #Spatialtechnology #machinelearning #ArtificalIntelligence #Precisionmedicine
https://t.co/2CPhWdP76j

[GlomCon @GlomCon]

Kidney Pathology Certificate Program

Starting January 2023

pre-register at https://t.co/8cCmqGBxRF

[Ibrahim Batal @IbrahimBatal9]

@AlcinoGama @ASNKidney @theglasspusher Congratulations 🍾

[Ibrahim Batal @IbrahimBatal9]

@MPAlexanderMD

[Ibrahim Batal @IbrahimBatal9]

Extremely honored to receive this year precision medicine award

[Herbert Irving Comprehensive Cancer Center @columbiacancer]

Five Columbia research teams have been awarded 2022 Precision Medicine Pilot Grants to advance the fields of cardiovascular disease, colorectal cancer, rare disease, organ transplant, and precision psychiatry.

Explore our winning projects below: https://t.co/2UP50V4MWM

[Ibrahim Batal @IbrahimBatal9]

@jradnephro @KIReports Congratulations

[Ibrahim Batal @IbrahimBatal9]

@WCMCPathology Congratulations

[Ibrahim Batal @IbrahimBatal9]

@NKF_NephPros @SumitMohanMD Congratulations

[Ibrahim Batal @IbrahimBatal9]

@RajguptaEM Interestingly we found that glomerulitis and high proteinuria are associated with worse prognosis in primary MN in the allograft (your pt have both plus low albumin). The glomerulitis in this case may not reflect AMR but stasis and may need to rule out renal vein thrombosis

[Ibrahim Batal @IbrahimBatal9]

@RajguptaEM Although no one will know for sure my impression is that AMR associated MGN is weak here for a few reasons: PLA2r is pos, DSA neg, C4d neg and ptc0-1 (none of these reasons by itself is definitive but the combination argues against this possibility). It is likely primary MN